KOS PHARMACEUTICALS INC 4/A
4/A · KOS PHARMACEUTICALS INC · Filed May 2, 2006
Insider Transaction Report
Form 4/AAmended
NOVITCH MARK M D
Director
Transactions
- Exercise/Conversion
Common Stock, $.01 par value
2005-08-10$24.69/sh+5,000$123,450→ 7,000 total - Sale
Common Stock, $.01 par value
2005-08-10$72.37/sh−5,000$361,850→ 2,000 total
Footnotes (1)
- [F1]The reporting person's original Form 4 incorrectly omitted 2,000 shares of the Issuer's Common Stock beneficially owned by the reporting person at the time of the reported transaction.